Rupei Tang

Title: Rupei Tang: Innovator in Pharmaceutical Adjuvants and Prodrugs

Introduction

Rupei Tang is a notable inventor based in Hefei, China. He has made significant contributions to the field of pharmaceutical adjuvants and drug delivery systems. With a focus on improving the safety and efficiency of pharmaceutical formulations, Tang has been awarded 2 patents for his innovative work.

Latest Patents

Tang's latest patents include a low-toxicity and high-efficiency orthoester mixture pharmaceutical adjuvant and a tetravalent platinum compound-bicyclic double-bond-containing amphiphilic polymer prodrug. The first patent describes an improved orthoester mixture that enhances biosafety by adjusting the substituent type and length of the orthoester compound. This innovation maintains the properties of the pharmaceutical adjuvant before and after the improvement. The second patent focuses on a novel prodrug that exhibits pH hypersensitivity and reduction dual responsiveness, along with a preparation method and application for the nano-micelle formed by the prodrug.

Career Highlights

Rupei Tang is affiliated with Anhui University, where he conducts research and development in pharmaceutical sciences. His work has garnered attention for its potential applications in drug delivery and therapeutic efficacy.

Collaborations

Tang collaborates with esteemed colleagues, including Guoqing Yan and Xin Wang, to advance research in his field. Their combined expertise contributes to the innovative projects undertaken at Anhui University.

Conclusion

Rupei Tang's contributions to pharmaceutical adjuvants and prodrugs highlight his commitment to enhancing drug safety and efficacy. His innovative patents reflect a dedication to improving healthcare solutions through scientific research.